Business Description
Sutro Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8693671021
Description
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.62 | |||||
| Equity-to-Asset | 0.25 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.28 | |||||
| Beneish M-Score | -1.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.9 | |||||
| 3-Year EBITDA Growth Rate | -9.8 | |||||
| 3-Year EPS without NRI Growth Rate | 0.2 | |||||
| 3-Year FCF Growth Rate | 5.7 | |||||
| 3-Year Book Growth Rate | -30.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -14.33 | |||||
| Future 3-5Y Total Revenue Growth Rate | -27.37 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.32 | |||||
| 9-Day RSI | 31.18 | |||||
| 14-Day RSI | 33.69 | |||||
| 6-1 Month Momentum % | -16.47 | |||||
| 12-1 Month Momentum % | 53.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.09 | |||||
| Quick Ratio | 3.09 | |||||
| Cash Ratio | 2.96 | |||||
| Days Sales Outstanding | 44.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -36.76 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -80.8 | |||||
| Net Margin % | -77.01 | |||||
| FCF Margin % | -67.85 | |||||
| ROE % | -99.41 | |||||
| ROA % | -27.58 | |||||
| ROIC % | -130.75 | |||||
| ROC (Joel Greenblatt) % | -173.04 | |||||
| ROCE % | -21.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.06 | |||||
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| EV-to-EBIT | 1.98 | |||||
| EV-to-EBITDA | 2.2 | |||||
| EV-to-Revenue | -0.9 | |||||
| EV-to-Forward-Revenue | 0.08 | |||||
| EV-to-FCF | 1.33 | |||||
| Price-to-Net-Current-Asset-Value | 3.35 | |||||
| Price-to-Net-Cash | 4.57 | |||||
| Earnings Yield (Greenblatt) % | 50.51 | |||||
| FCF Yield % | -49.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:STRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sutro Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 160.955 | ||
| EPS (TTM) ($) | -1.61 | ||
| Beta | 1.51 | ||
| Volatility % | 104.06 | ||
| 14-Day RSI | 33.69 | ||
| 14-Day ATR ($) | 0.263641 | ||
| 20-Day SMA ($) | 3.3125 | ||
| 12-1 Month Momentum % | 53.68 | ||
| 52-Week Range ($) | 2.45 - 6.13 | ||
| Shares Outstanding (Mil) | 82.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sutro Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sutro Biopharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sutro Biopharma Inc Frequently Asked Questions
What is Sutro Biopharma Inc(STRO)'s stock price today?
The current price of STRO is $2.65. The 52 week high of STRO is $6.13 and 52 week low is $2.45.
When is next earnings date of Sutro Biopharma Inc(STRO)?
The next earnings date of Sutro Biopharma Inc(STRO) is 2025-03-25 Est..
Does Sutro Biopharma Inc(STRO) pay dividends? If so, how much?
Sutro Biopharma Inc(STRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers